Found: 16
Select item for more details and to access through your institution.
Neonatal IVC thrombosis in a baby born to an aPL positive mother – a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 453, doi. 10.1177/09612033231153536
- By:
- Publication type:
- Article
Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 424, doi. 10.1177/09612033231153791
- By:
- Publication type:
- Article
What you need to know about migraine in Hughes syndrome patients.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 319, doi. 10.1177/09612033231153790
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 431, doi. 10.1177/09612033231151603
- By:
- Publication type:
- Article
The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 401, doi. 10.1177/09612033231151600
- By:
- Publication type:
- Article
Predicting kidney outcomes among Latin American patients with lupus nephritis: The prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammation.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 411, doi. 10.1177/09612033231151597
- By:
- Publication type:
- Article
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 394, doi. 10.1177/09612033221151012
- By:
- Publication type:
- Article
Unilateral lupus mastitis.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 380, doi. 10.1177/09612033221149884
- By:
- Publication type:
- Article
Possible relationship between hydroxychloroquine and electrocardiographic and echocardiographic abnormalities in patients with inflammatory rheumatic diseases––a monocentric study.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 388, doi. 10.1177/09612033221149875
- By:
- Publication type:
- Article
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 444, doi. 10.1177/09612033221149874
- By:
- Publication type:
- Article
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 352, doi. 10.1177/09612033221148334
- By:
- Publication type:
- Article
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 363, doi. 10.1177/09612033221148099
- By:
- Publication type:
- Article
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 342, doi. 10.1177/09612033221147479
- By:
- Publication type:
- Article
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.
- Published in:
- Lupus, 2023, v. 32, n. 3, p. 325, doi. 10.1177/09612033221147471
- By:
- Publication type:
- Article